Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 4, 2025
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
GlobeNewswire
·
September 4, 2025
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025. The …
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
GlobeNewswire
·
September 4, 2025
HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Service Coordination, Inc. President & CEO John Dumas Named One of Maryland’s 2025 Most Admired CEOs
GlobeNewswire
·
September 4, 2025
Frederick, MD, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Daily Record has named John Dumas, President …
Silent Killer: HTLV 2026 Conference Launches Global Campaign to Fight HIV’s “Cousin” Virus Infecting Millions
GlobeNewswire
·
September 4, 2025
Philadelphia, PA , Sept. 04, 2025 (GLOBE NEWSWIRE) -- HTLV 2026, the international conference dedicated to advance discovery research on Human T-cell Leukemia Virus Type 1 (HTLV-1), today announced the launch of a global awareness campaign to combat the …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
GlobeNewswire
·
September 4, 2025
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 4, 2025
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire
·
September 4, 2025
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Indaptus Therapeutics Provides Clinical Update
GlobeNewswire
·
September 4, 2025
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
Inventiva to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
GlobeNewswire
·
September 4, 2025
The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone. Covering five rare disease eligible indications, the accessible market in the US could be as high as 40,000 patients. Focused on improved …
What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era
GlobeNewswire
·
September 4, 2025
DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Institutions, and organizations across the life sciences continuum are seeking clarity on how federal research and development (R…
Rise of Weed Pollen and Return to School Ushers in Sneezing Season
GlobeNewswire
·
September 4, 2025
Washington, DC, Sept. 04, 2025 (GLOBE NEWSWIRE) -- If you’re sneezing this season, the reason could be a respiratory infection or weed pollen allergy. A review of pollen counts from cities across the country reveals a rise in levels of ragweed pollen as …
ProductLife Group expandiert nach Japan und bietet lokales Fachwissen sowie verbesserten Kundensupport
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Die ProductLife Group (PLG) freut sich, die Eröffnung ihrer neuesten Niederlassung in Japan bekannt zu geben und damit ihr Engagement für die Erfüllung der sich wandelnden Kundenbedürfnisse und Marktanforderungen …
ProductLife Group s’agrandit pour offrir une expertise localisée et un service client amélioré au Japon
GlobeNewswire
·
September 4, 2025
PARIS, 04 sept. 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) est fier d’annoncer l’ouverture de son tout nouveau bureau au Japon, venant réaffirmer son engagement à répondre aux besoins changeants de ses clients et aux exigences du marché. Cet …
ProductLife Group Memperluas Layanan untuk Keahlian Lokal & Dukungan Klien yang Lebih Baik di Jepang
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangga mengumumkan pembukaan kantor barunya di Jepang, menguatkan komitmennya untuk memenuhi kebutuhan klien dan tuntutan pasar yang terus berkembang. Ekspansi ini meningkatkan …
ProductLife Group, 일본에 진출하며 현지 전문성 강화 및 고객 지원 확대
GlobeNewswire
·
September 4, 2025
파리, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG)이 일본에 신규 사무소를 개소하게 되었다고 발표했다. 이번 확장은 변화하는 고객의 니즈와 시장 수요에 부응하겠다는 PLG의 의지를 강화하는 한편, 역량을 확대하고 지역 및 글로벌 네트워크를 강화하며, 추가 시장과 서비스 지원을 위한 원활한 협업을 가능하게 한다는 취지로 평가된다. 생명과학 기업들이 전 세계적 전문성과 현지 인재를 점점 더 필요로 …
ProductLife Group Mengembangkan Operasi untuk Menyampaikan Kepakaran Setempat dan Sokongan Klien yang Dipertingkatkan di Jepun
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangganya mengumumkan pembukaan pejabat terbaharu di Jepun, sekali gus memperkukuh komitmennya untuk memenuhi keperluan klien yang semakin berkembang serta tuntutan pasaran yang …
ProductLife Group…
GlobeNewswire
·
September 4, 2025
ปารีส, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) ภูมิใจที่จะประกาศการเปิดสำนักงานใหม่ล่าสุดในประเทศญี่ปุ่น เพื่อเสริมสร้างความมุ่งมั่นในการตอบสนองความต้องการของลูกค้าที่เปลี่ยนแปลงและความต้องการของตลาด การขยายตัวนี้ช่วยเพิ่มขีดความสามารถ …
ProductLife Group 在日本拓展业务，旨在提供本地化专业技术，增强客户支持
GlobeNewswire
·
September 4, 2025
巴黎, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) 欣然宣布其在日本最新设立的办事处正式开业。此举进一步彰显了本公司致力于满足不断变化的客户需要和市场需求的坚定承诺。 此次拓展将增强公司的业务实力，巩固其区域和全球网络，促进无缝协作，从而为更多市场和服务提供支持。 随着生命科学公司越来越重视全球专业技术与本地化人才的结合，PLG 的持续发展可确保客户能够依托深厚的行业知识和全球互联团队的紧密协作，获得量身定制的解决方案。 …